News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
February, 2025
February 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
2425262728  
Francisco J. Esteva: The practical implications of HER2-Low and HER2-Ultralow breast cancer
Francisco J. Esteva/LinkedIn
Feb 27, 2025, 11:33

Francisco J. Esteva: The practical implications of HER2-Low and HER2-Ultralow breast cancer

Francisco J. Esteva, Chief of the Division of Hematology and Medical Oncology at Lenox Hill Hospital and a Professor of Medicine at the Zucker School of Medicine, shared an article by Kathy D. Miller, et al. on LinkedIn:

“Excited to share my latest podcast episode with Dr. Kathy Miller, where we discuss the practical implications of HER2-Low and HER2-Ultralow breast cancer.

We explore how these evolving classifications impact treatment decisions and patient care.

Listen here.

A must-listen for oncologists, surgeons, researchers, and anyone interested in the future of precision oncology!”

New Classification of HER2–Ultra-Low Breast Cancer: What Do We Need to Know?

Francisco J. Esteva: The practical implications of HER2-Low and HER2-Ultralow breast cancer

Breast Cancer cancer fight against cancer Francisco J. Esteva global fight against cancerCancer Hematology HER2 Kathy D. Miller Lenox Hill Hospital MedOnc OncoDaily Oncology Precision Oncology Zucker School of Medicine
Special Coverage
Science
Feb 27, 2025, 11:33
Francisco J. Esteva: The practical implications of HER2-Low and HER2-Ultralow breast cancer
Blog
Feb 27, 2025, 11:23
Ramy Sedhom: Mental health is cancer care, and every person deserves support
Blog
Feb 27, 2025, 11:22
A game-changer for Childhood Cancer in India - CancerWorld
Blog
Feb 27, 2025, 11:17
ASCO/AACR Methods in Clinical Cancer Research Workshop
Science
Feb 27, 2025, 11:09
Nitin Jain: Treatment-free remission in Ph+ ALL
Blog
Feb 27, 2025, 11:00
Fadila Kouhen: I had the privilege of co-moderating a urology workshop at the Onco-Urology Congress in Fès
Blog
Feb 27, 2025, 10:58
Abstract submission deadline is approaching for the 7th National Congress of STOR - ESTRO
Drugs
Feb 27, 2025, 10:49
Venclexta (Venetoclax): Uses in Cancer, Side Effects, Dosages, Expectations
Blog
Feb 27, 2025, 10:35
Benjamin Schrank: An antibody-toxin conjugate that enhances immune recognition of tumors
Blog
Feb 27, 2025, 10:17
Stewart Campbell: Positive data from NP-G2-044 trial in patients with advanced and metastatic solid tumors
Drugs
Feb 27, 2025, 10:06
FDA Grants Priority Review to Merck’s Application for KEYTRUDA® (pembrolizumab) Plus Standard of Care as Perioperative Treatment for Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma
Blog
Feb 27, 2025, 10:03
Tanja Obradovic: New option of immunotherapy for HNSCC is on the horizon